Explore
Validate
Learn
Immunocytochemistry
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA062230 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA062230, RRID:AB_2684718
- Product name
- Anti-MAGEC2
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human MAGEC2, Gene description: melanoma antigen family C, 2, Alternative Gene Names: CT10, MAGE-C2, MAGEE1, Validated applications: ICC, IHC, Uniprot ID: Q9UBF1, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Combinations of EGFR and MET inhibitors reduce proliferation and invasiveness of mucosal melanoma cells
Engineering Cancer/Testis Antigens With Reversible S-Cationization to Evaluate Antigen Spreading
Immunological responses to adjuvant vaccination with combined CD1c+ myeloid and plasmacytoid dendritic cells in stage III melanoma patients
Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer
Profiling cancer testis antigens in non-small-cell lung cancer.
Simiczyjew A, Wądzyńska J, Kot M, Ziętek M, Matkowski R, Hoang M, Donizy P, Nowak D
Journal of Cellular and Molecular Medicine 2023;27(19):2995-3008
Journal of Cellular and Molecular Medicine 2023;27(19):2995-3008
Engineering Cancer/Testis Antigens With Reversible S-Cationization to Evaluate Antigen Spreading
Miyamoto A, Honjo T, Masui M, Kinoshita R, Kumon H, Kakimi K, Futami J
Frontiers in Oncology 2022;12
Frontiers in Oncology 2022;12
Immunological responses to adjuvant vaccination with combined CD1c+ myeloid and plasmacytoid dendritic cells in stage III melanoma patients
Bloemendal M, Bol K, Boudewijns S, Gorris M, de Wilt J, Croockewit S, van Rossum M, de Goede A, Petry K, Koornstra R, Figdor C, Gerritsen W, Schreibelt G, de Vries I
OncoImmunology 2021;11(1)
OncoImmunology 2021;11(1)
Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer
Westdorp H, Creemers J, van Oort I, Schreibelt G, Gorris M, Mehra N, Simons M, de Goede A, van Rossum M, Croockewit A, Figdor C, Witjes J, Aarntzen E, Mus R, Brüning M, Petry K, Gotthardt M, Barentsz J, de Vries I, Gerritsen W
Journal for ImmunoTherapy of Cancer 2019;7(1)
Journal for ImmunoTherapy of Cancer 2019;7(1)
Profiling cancer testis antigens in non-small-cell lung cancer.
Djureinovic D, Hallström BM, Horie M, Mattsson JSM, La Fleur L, Fagerberg L, Brunnström H, Lindskog C, Madjar K, Rahnenführer J, Ekman S, Ståhle E, Koyi H, Brandén E, Edlund K, Hengstler JG, Lambe M, Saito A, Botling J, Pontén F, Uhlén M, Micke P
JCI insight 2016 Jul 7;1(10):e86837
JCI insight 2016 Jul 7;1(10):e86837
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Orthogonal validation
- Main image
- Experimental details
- Immunohistochemistry analysis in human testis and kidney tissues using HPA062230 antibody. Corresponding MAGEC2 RNA-seq data are presented for the same tissues.
- Sample type
- Human
- Protocol
- Protocol
